Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...

UAE retail investors are showing strong conviction in the long-term potential of electric vehicles and emerging tech, with ...

The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...